Recall Register

Drug recall: Morphine Sulfate 1 mg/mL (preservative free; sulfite free) 2 mL fill 3 mL syringe, SCA Pharmaceuticals, LLC, Windsor, CT

Class II FDA enforcement event 80303. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

SCA Pharmaceuticals, LLC started this drug recall on 14 Jun 2018. The firm address in the FDA record is in Windsor, CT. FDA put the recall in Class II. FDA event 80303 has 12 product records. The first FDA enforcement report date is 11 Jul 2018. The record gives the status Terminated, with the termination date 4 Feb 2019.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Product was distributed throughout the United States.

Recalling firm

SCA Pharmaceuticals, LLC, Windsor, CT.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

12 product records in the event.

FDA event 80303: product records
Recall numberProductQuantityClassStatusReport date
D-0894-2018Morphine Sulfate 1 mg/mL (preservative free; sulfite free) 2 mL fill 3 mL syringe, SCA Pharmaceuticals, LLC, Windsor, CT440 syringesClass IITerminated11 Jul 2018
D-0895-2018Fentanyl (as citrate) 10 mcg/mL in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT492 bagsClass IITerminated11 Jul 2018
D-0896-2018Fentanyl (as citrate) 2 mcg/mL + Bupivacaine HCL 0.0625% in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT179 bagsClass IITerminated11 Jul 2018
D-0897-2018Diltiazem HCL 1 mg/mL in 125 mL 0.9% Sodium Chloride 100 mL bag (total volume 125 mL) (125 mg), SCA Pharmaceuticals, LLC, Windsor, CT2,869 bagsClass IITerminated11 Jul 2018
D-0898-2018Norepinephrine Bitartrate 4 mg (16 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT2,268 bagsClass IITerminated11 Jul 2018
D-0899-2018Norepinephrine Bitartrate 8 mg (32 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT1,882 bagsClass IITerminated11 Jul 2018
D-0900-2018Norepinephrine Bitartrate 16 mg (64 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT1,397 bagsClass IITerminated11 Jul 2018
D-0901-2018Phenylephrine HCL 10 mg in 0.9% Sodium Chloride 250 mL Bag (40 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT451 bagsClass IITerminated11 Jul 2018
D-0902-2018Phenylephrine HCL 40 mg in 0.9% Sodium Chloride 250 mL Bag (160 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT451 bagsClass IITerminated11 Jul 2018
D-0903-2018Phenylephrine HCL 20 mg in 0.9% Sodium Chloride 250 mL Bag (160 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT400 bagsClass IITerminated11 Jul 2018
D-0904-2018Phenylephrine HCL 50 mg in 0.9% Sodium Chloride 250 mL Bag (200 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CTClass IITerminated11 Jul 2018
D-0905-2018Phenylephrine HCL 80mg in 0.9% Sodium Chloride 250 mL Bag (320 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT196 bagsClass IITerminated11 Jul 2018

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2018
367
Share of these events in Class II
60%
Product records in this event
12Median of the firm: 10
Events of the firm on the register
6

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 80303. https://recallregister.com/fda/ii/80303/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Product was distributed throughout the United States.
What quantity of product is in FDA event 80303?
The event has 12 product records. The first record gives this quantity: 440 syringes
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2018 have the same class?
60% of the 367 drug events that started in 2018 are in Class II.